Cuprina Holdings (Cayman) Ltd (CUPR)

NASD · Healthcare · Medical Instruments & Supplies · Singapore

Cuprina Holdings (Cayman) Ltd is a micro cap company (market value under $300 million) in the Medical Instruments & Supplies industry.

Intrinsic value, DCF valuation, financial health and value investing analysis for the Cuprina Holdings (Cayman) Ltd stock.

Our verdict on CUPR

Overvalued: intrinsic value $0.40 per share, market price $1.77, margin of safety -343.2% (as of 2026-10-30).

A 0.6x revenue multiple, discounted for its losses, values the shares at $0.40; the price of $1.77 is 343% above that value.

Browse

• Stocks in Singapore

Peers in Medical Instruments & Supplies

• Intuitive Surgical Inc (ISRG)
• Becton Dickinson & Co (BDX)
• Medline Inc (MDLN)
• Alcon Inc (ALC)
• Resmed Inc (RMD)
• West Pharmaceutical Services Inc (WST)
• Solventum Corp (SOLV)
• Baxter International Inc (BAX)

All 51 Medical Instruments & Supplies stocks

Cheaper than CUPR in Medical Instruments & Supplies

• Solventum Corp (SOLV): undervalued, 50% margin of safety
• Pro-Dex Inc (PDEX): slightly undervalued, 11% margin of safety
• Resmed Inc (RMD): slightly undervalued, 7% margin of safety
• Cooper Companies Inc (COO): fairly valued, 3% margin of safety
• Becton Dickinson & Co (BDX): slightly overvalued, -6% margin of safety
• Aptargroup Inc (ATR): slightly overvalued, -12% margin of safety

19 more in this industry show a wider margin of safety.

Is CUPR undervalued or overvalued?

CUPR is overvalued (as of the 2026-10-30 close). A 0.6x revenue multiple, discounted for its losses, values the shares at $0.40; the price of $1.77 is 343% above that value.

What is the intrinsic value of CUPR?

$0.40 per share (as of the 2026-10-30 close), against a market price of $1.77. That is a margin of safety of -343.2%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.